Waverly Advisors’s Astera Labs ALAB Stock Holding History

Waverly Advisors’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$628K	Buy	+1,300	New	+$345K	﹤0.01%	1064

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Waverly Advisors's ALAB Position: Q2 2026 in Review

Waverly Advisors increased its Astera Labs (ALAB) stake by 27% in Q2 2026, buying an estimated $158K and bringing the position to 2,778 shares worth $1.34M. The position accounts for 0.01% of the portfolio, ranked #807.

Waverly Advisors first reported a position in ALAB in Q3 2025 and has held it in 4 quarters since. 993 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

Waverly Advisors held 2,778 shares of Astera Labs worth $1.34M as of Q2 2026.
Waverly Advisors bought 595 Astera Labs shares in Q2 2026, an estimated $158K.
Astera Labs made up 0.01% of Waverly Advisors's portfolio in Q2 2026, its #807 holding.
Waverly Advisors first reported a position in Astera Labs in Q3 2025 and has held it in 4 quarters since.
993 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Waverly Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.